Which is better for the pink eye?

Health and Human Services Secretary Sylvia Burwell and President Donald Trump have a disagreement about the use of strong medicine and pink eye medicine.

Trump said in a statement Tuesday that Burwell’s remarks were inappropriate.

“This is one of the most serious allegations in our history, and she should apologize for her offensive remarks.

She should also apologize for using the word ‘pink’ in describing medicine,” Trump said.

The White House has not released a statement.

Burwell, who is the only member of Trump’s Cabinet to be named to a Cabinet position, has been at the center of several controversies in recent months.

In January, she was caught on tape making racist comments to an employee of a Florida-based private hospital.

The remarks sparked an investigation by the Federal Bureau of Investigation, which concluded that Burrow violated hospital policies, including those prohibiting discrimination based on race and ethnicity.

She has also been criticized for suggesting that people with disabilities should not use their own money to pay for their medical care.

A Trump administration official told CNN that the White House does not have a position on Burwell or the issue of pink eye medicines.

Trump also has not said whether he will take steps to prevent the CDC from funding any additional research on the subject.